Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Honig

Showing results (191-200 of 273) with videos related to

Pageof 28
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionAli S Ropri, Tiffany G Lam, Vrinda Kalia, et al.
Neurology|July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy BodiesDavid G Coughlin, Karen R MacLeod, John S Middleton, et al.
Nature Communications|April 9, 2025
GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tauDiana Acosta Ingram, Emir Turkes, Tae Yeon Kim, et al.
JAMA Neurology|September 19, 2022
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled TrialsSusanne Ostrowitzki, Tobias Bittner, Kaycee M Sink, et al.
Movement Disorders Clinical Practice|January 10, 2026
Voice and Speech in Atypical Parkinsonian DisordersFederico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2023
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies ConsortiumLavanya Jain, Maria Khrestian, Shane Formica, et al.
Frontiers in Aging Neuroscience|July 5, 2022
Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention TrialsAndrew J Aschenbrenner, Jason Hassenstab, Guoqiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 12, 2025
APOE and Alzheimer's disease and related dementias risk among 12,221 Hispanics/LatinosSandra Barral, Zikun Yang, Nicole Phillips, et al.
Acta Neuropathologica|April 7, 2022
Wolframin is a novel regulator of tau pathology and neurodegenerationShuo Chen, Diana Acosta, Liangping Li, et al.
Pageof 28

Showing results (191-200 of 273) with videos related to

Sort By:
Pageof 28
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 28, 2024
Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expressionAli S Ropri, Tiffany G Lam, Vrinda Kalia, et al.
Neurology|July 16, 2024
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy BodiesDavid G Coughlin, Karen R MacLeod, John S Middleton, et al.
Nature Communications|April 9, 2025
GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tauDiana Acosta Ingram, Emir Turkes, Tae Yeon Kim, et al.
JAMA Neurology|September 19, 2022
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled TrialsSusanne Ostrowitzki, Tobias Bittner, Kaycee M Sink, et al.
Movement Disorders Clinical Practice|January 10, 2026
Voice and Speech in Atypical Parkinsonian DisordersFederico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2024
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 23, 2023
ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies ConsortiumLavanya Jain, Maria Khrestian, Shane Formica, et al.
Frontiers in Aging Neuroscience|July 5, 2022
Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention TrialsAndrew J Aschenbrenner, Jason Hassenstab, Guoqiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 12, 2025
APOE and Alzheimer's disease and related dementias risk among 12,221 Hispanics/LatinosSandra Barral, Zikun Yang, Nicole Phillips, et al.
Acta Neuropathologica|April 7, 2022
Wolframin is a novel regulator of tau pathology and neurodegenerationShuo Chen, Diana Acosta, Liangping Li, et al.
Pageof 28